HUTCHMED (China) Limited

HCMNASDAQHealthcare● Active

$10.84

$-0.04(-0.32%)

Market Cap$1.9B

P/E Ratio—

52W High$19.5

52W Low$10.71

Avg Volume39K

Open$10.90

Beta0.37

Overview

HUTCHMED (China) Limited（HCM）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

hcm · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 10 位华尔街分析师

Buy

10 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 10 · 买入占比: 80.0%

12 个月目标价

High

$13.60

Consensus

$13.60

+25.3% upside

Low

$13.60

Median: $13.6 · Last Close: $10.86

HUTCHMED (China) Limited（HCM）的分析师共识为 Buy，基于过去 3 个月内 10 位华尔街分析师的评级。HCM 的 12 个月平均目标价为 $13.60，相对当前价 $10.86 代表 +25.3% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$10.35	↓ 4.62%	$10.31	$10.40

1-day model range: $10.31–$10.4. Peak: $10.4 (-4.62%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$9	$9	$9	-16.9%
2028	$8	$8	$8	-24.6%
2029	$8	$8	$8	-28.4%
2030	$7	$8	$8	-30.4%
2031	$7	—	$8	-31.5%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%

1Buy

0Neutral

13Sell

RSI (14)25.7Oversold

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · HCM · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$11.15SELL

MA 10$11.33SELL

MA 20$11.83SELL

MA 50$13.40SELL

MA 100$14.04SELL

MA 200$14.52SELL

Current $HCM · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$11.08SELL

EMA 10$11.34SELL

EMA 20$11.84SELL

EMA 50$12.85SELL

EMA 100$13.58SELL

EMA 200$14.26SELL

Current $HCM · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-03-10	B of A Securities	Maintains	Buy→Buy
2025-09-22	Morgan Stanley	Downgrade ↓	Equal Weight→Underweight
2025-07-22	B of A Securities	Maintains	Buy→Buy
2024-08-01	Goldman Sachs	Maintains	Neutral→Neutral
2023-11-24	Deutsche Bank	Upgrade ↑	Hold→Buy
2023-11-10	Goldman Sachs	Maintains	Neutral→Neutral
2023-09-05	Cantor Fitzgerald	Maintains	Overweight→Overweight
2023-07-24	Cantor Fitzgerald	Maintains	Overweight→Overweight
2022-08-09	Goldman Sachs	Maintains	Neutral→Neutral
2022-08-02	Goldman Sachs	Maintains	Neutral→Neutral

B of A Securities2026-03-10

Maintains

Buy→Buy

Morgan Stanley2025-09-22

Downgrade ↓

Equal Weight→Underweight

B of A Securities2025-07-22

Maintains

Buy→Buy

Goldman Sachs2024-08-01

Maintains

Neutral→Neutral

Deutsche Bank2023-11-24

Upgrade ↑

Hold→Buy

Goldman Sachs2023-11-10

Maintains

Neutral→Neutral

Cantor Fitzgerald2023-09-05

Maintains

Overweight→Overweight

Cantor Fitzgerald2023-07-24

Maintains

Overweight→Overweight

Goldman Sachs2022-08-09

Maintains

Neutral→Neutral

Goldman Sachs2022-08-02

Maintains

Neutral→Neutral

Wall Street analysts have recently issued updated ratings on HUTCHMED (China) Limited (HCM) stock. Of the recent 20 rating actions, 1 were upgrades and 2 were downgrades. 10 analysts currently cover HCM.

分析师推荐趋势

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

HCM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$639M

↓ 23.4% YoY

Revenue Next Year

$738M

↑ 15.4% YoY

EPS This Year

$0.32

EPS Next Year

$0.45

↑ 40.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast HCM EPS of $0.32 for the current fiscal year, based on estimates from 4 analysts. The HCM revenue forecast is $639M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

HCM 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。HCM 的共识目标价为 $13.60（+25.3% 上行空间），分析师共识为 Buy。

HCM 的短期预测（明日）为 $10.35（-4.62%）。 HCM 对 2027 年的股价预测均值为 $9。 HCM 对 2030 年的预测区间为 $7–$8。

HUTCHMED (China) Limited 在 NASDAQ 上市，代码 HCM。HCM 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

HCM 预测 · 8 个问题

根据 10 位华尔街分析师，HCM 的 12 个月平均目标价为 $13.60，最高 $13.60、最低 $13.60。若有图表，中位目标价可在上方查看。相对当前价 $10.86，隐含约 +25.3% 的上行空间。

HCM 目标价HCM 分析师目标价HCM 12个月目标价目标价 HCM

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.